HomeBusinessHealthcare Industry Stock NewsSkye Bioscience (SKYE) CEO on Drug Development

Skye Bioscience (SKYE) CEO on Drug Development

Skye Bioscience (SKYE) focuses on developing proprietary molecules to treat diseases involving inflammatory, fibrotic, and metabolic conditions. CEO Punit Dhillon joins Nicole Petallides to discuss the latest in drug development. He also talks about the competition in the obesity space. Tune in to find out more about the stock market today.

Trading 360

14 May 2024

SHARE

ON AIR
12:00 am
Gamma On
replay
ON AIR
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
education
3:30 am
Your First Trade
REPLAY
4:00 am
Trading 360
REPLAY
5:00 am
Fast Market
REPLAY
6:00 am
Market Overtime
REPLAY
education
6:30 am
Inside the Mind of a Trader
REPLAY
education
7:00 am
Inside the Mind of a Trader
REPLAY
education
7:30 am
Inside the Mind of a Trader
REPLAY
8:00 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:30 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
education
11:30 am
Inside the Mind of a Trader
REPLAY
education
12:00 pm
Inside the Mind of a Trader
REPLAY
education
12:30 pm
Inside the Mind of a Trader
REPLAY
education
1:00 pm
Your First Trade
REPLAY
education
1:30 pm
Your First Trade
REPLAY
education
2:00 pm
Your First Trade
REPLAY
education
2:30 pm
Your First Trade
REPLAY
education
3:00 pm
Your First Trade
REPLAY
3:30 pm
Market Overtime
REPLAY
4:00 pm
Next Gen Investing
REPLAY
5:00 pm
Gamma On
REPLAY
5:30 pm
Gamma On
REPLAY
6:00 pm
Gamma On
REPLAY
6:30 pm
Gamma On
REPLAY
7:30 pm
Gamma On
REPLAY
8:00 pm
Gamma On
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Get the Market Minute

Daily insights for every investor